{"changes":[],"country":"GB","description":"Pathios Therapeutics is a clinical-stage oncology and immunology company targeting GPR65, an acid-sensing receptor on immune cells. It serves patients with solid tumors who could benefit from a new immunotherapy. It inhibits GPR65 to fix immune dysfunction in the acidic tumor microenvironment.","domain":"pathiostherapeutics.com","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":51.752013,"lng":-1.25785,"location":"Oxford, UK","name":"Pathios Therapeutics","rounds":[{"amountQuarantined":false,"amountUsd":25272000,"currency":"EUR","date":"2024-04-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"pathiostherapeutics-com","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"pathiostherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://pathiostherapeutics.com"},{"fact":"description","publisher":"pathiostherapeutics.com","retrievedAt":"2026-05-07","status":"self-reported","url":"https://pathiostherapeutics.com"}],"stage":"series-b+","techStack":["WordPress 6.9.4","Modernizr","Yoast SEO 27.5","reCAPTCHA","Google Analytics","Google Hosted Libraries","Google Maps","Google Tag Manager","Flywheel 5.1.0","DoubleClick Floodlight","Contact Form 7 6.1.5","CookieYes 3.4.2"],"totalRaisedUsd":25272000,"updatedAt":"2026-05-07"}